Traws Pharma (TRAW) Assets Average (2013 - 2026)
Traws Pharma (TRAW) posted quarterly Assets Average of $9.4 million for Q1 2026, down 57.36% year-over-year from $22.0 million in Q1 2025, and down 18.59% quarter-over-quarter from $11.5 million in Q4 2025.
Traws Pharma (TRAW) Assets Average (2013 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Assets Average for 14 consecutive years, with $9.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average fell 57.36% year-over-year to $9.4 million; the TTM figure through Mar 2026 stood at $9.4 million (down 57.36% YoY), while the FY2025 annual figure was $17.8 million, down 25.32% from the prior year.
- Assets Average slipped to $9.4 million in Q1 2026 per TRAW's latest filing, from $11.5 million in the prior quarter.
- Across five years, Assets Average topped out at $53.4 million in Q1 2022 and bottomed at $9.4 million in Q1 2026.
- Historically, Assets Average has averaged $27.0 million across 5 years, with a median of $22.0 million in 2025.
- Annual changes were most pronounced in 2022 — Assets Average soared 55.3% — and 2026, when it slumped 57.36%.
- Traws Pharma's Assets Average stood at $41.6 million in 2022, then plunged by 40.2% to $24.9 million in 2023, then slumped by 31.82% to $16.9 million in 2024, then slumped by 31.97% to $11.5 million in 2025, then dropped by 18.59% to $9.4 million in 2026.
- Business Quant data shows TRAW's Assets Average at $9.4 million in Q1 2026, $11.5 million in Q4 2025, and $14.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Traws Pharma | 5.60 Mn | 588,417.40 | - | 9.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.39 Mn |
| Dec 31, 2025 | 11.53 Mn |
| Sep 30, 2025 | 14.03 Mn |
| Jun 30, 2025 | 17.34 Mn |
| Mar 31, 2025 | 22.01 Mn |
| Dec 31, 2024 | 16.95 Mn |
| Sep 30, 2024 | 13.81 Mn |
| Jun 30, 2024 | 18.43 Mn |
| Mar 31, 2024 | 20.43 Mn |
| Dec 31, 2023 | 24.86 Mn |
| Sep 30, 2023 | 28.75 Mn |
| Jun 30, 2023 | 32.76 Mn |
| Mar 31, 2023 | 37.22 Mn |
| Dec 31, 2022 | 41.58 Mn |
| Sep 30, 2022 | 45.93 Mn |
| Jun 30, 2022 | 49.75 Mn |
| Mar 31, 2022 | 53.45 Mn |
| Dec 31, 2021 | 57.73 Mn |
| Sep 30, 2021 | 52.18 Mn |
| Jun 30, 2021 | 46.61 Mn |